Citation: Jf. Howes et Pa. Asbell, A DOUBLE-MASKED PLACEBO-CONTROLLED, EVALUATION OF THE EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE IN THE TREATMENT OF CONTACT-LENS ASSOCIATED GIANT PAPILLARY CONJUNCTIVITIS, Investigative ophthalmology & visual science, 36(4), 1995, pp. 630-630
Authors:
GARTY N
MELAMED S
TICHO U
ZALISH M
HOWES JF
RACHMIEL R
GREENBAUM A
NEUMANN R
Citation: N. Garty et al., ADAPROLOL - A SITE ACTIVE BETA-BLOCKER FOR THE TREATMENT OF GLAUCOMA - A 2-WEEK CLINICAL-TRIAL, Investigative ophthalmology & visual science, 36(4), 1995, pp. 736-736
Citation: Jf. Howes et al., LOTEPREDNOL ETABONATE - COMPARISON WITH OTHER STEROIDS IN 2 MODELS OFINTRAOCULAR INFLAMMATION, Journal of ocular pharmacology, 10(1), 1994, pp. 289-293
Authors:
MELAMED S
KURTZ S
GREENBAUM A
HOWES JF
NEUMANN R
GARTY N
Citation: S. Melamed et al., ADAPROLOL MALEATE IN SUBMICRON EMULSION - A NOVEL SOFT B-BLOCKING AGENT, IS SAFE AND EFFECTIVE IN HUMAN STUDIES, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1387-1387
Authors:
BEILIN M
BARILAN A
BELKIN M
HOWES JF
NEUMANN R
Citation: M. Beilin et al., MECHANISTIC STUDIES ON THE IOP LOWERING EFFECT OF SYSTEMIC HU-211, A NONPSYCHOTROPIC CANNABINOID, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1400-1400
Authors:
NEUMANN R
BEILIN M
BELKIN M
BODOR N
HOWES JF
BARILAN A
Citation: R. Neumann et al., ADAPROLOL - A NOVEL SOFT BETA-BLOCKER REDUCES IOP WITH NO APPARENT HEMODYNAMIC-EFFECT, Investigative ophthalmology & visual science, 35(4), 1994, pp. 2048-2048
Authors:
GARTY N
LUSKY M
ZALISH M
RACHMIEL R
GREENBAUM A
DESATNIK H
NEUMANN R
HOWES JF
MELAMED S
Citation: N. Garty et al., PILOCARPINE IN SUBMICRON EMULSION FORMULATION FOR TREATMENT OF OCULARHYPERTENSION - A PHASE-II CLINICAL-TRIAL, Investigative ophthalmology & visual science, 35(4), 1994, pp. 2175-2175
Citation: Jf. Howes, THE CROSS AND THE RISING SUN, VOL 2, THE BRITISH PROTESTANT MISSIONARY MOVEMENT IN JAPAN, KOREA, AND TAIWAN, 1865-1945 - ION,AH, Pacific affairs, 67(1), 1994, pp. 102-103
Authors:
HOCHHAUS G
DRUZGALA P
HOWES JF
BODOR N
DERENDORF H
Citation: G. Hochhaus et al., PHARMACOKINETIC CHARACTERIZATION AND TISSUE DISTRIBUTION OF THE NEW GLUCOCORTICOID SOFT DRUG LOTEPREDNOL ETABONATE IN RATS AND DOGS - RESPONSE, Journal of pharmaceutical sciences, 83(7), 1994, pp. 1067-1068
Authors:
BARTLETT JD
HORWITZ B
LAIBOVITZ R
HOWES JF
Citation: Jd. Bartlett et al., INTRAOCULAR-PRESSURE RESPONSE TO LOTEPREDNOL ETABONATE IN KNOWN STEROID RESPONDERS, Journal of ocular pharmacology, 9(2), 1993, pp. 157-165
Authors:
BARTLETT JD
HOWES JF
GHORMLEY NR
AMOS JF
LAIBOVITZ R
HORWITZ B
Citation: Jd. Bartlett et al., SAFETY AND EFFICACY OF LOTEPREDNOL ETABONATE FOR TREATMENT OF PAPILLAE IN CONTACT LENS-ASSOCIATED GIANT PAPILLARY CONJUNCTIVITIS, Current eye research, 12(4), 1993, pp. 313-321
Citation: R. Laibovitz et al., SAFETY EVALUATION OF THE INTRAOCULAR-PRESSURE RESPONSE TO LOTEPREDNOLETABONATE IN HIGH STEROID RESPONDERS, Investigative ophthalmology & visual science, 33(4), 1992, pp. 1121-1121
Authors:
HOWES JF
BARTLETT JD
GHORMLEY NR
AMOS JF
LAIBOVITZ R
HORWITZ B
Citation: Jf. Howes et al., SAFETY AND EFFICACY OF LOTEPREDNOL ETABONATE FOR TREATMENT OF GIANT PAPILLARY CONJUNCTIVITIS, Investigative ophthalmology & visual science, 33(4), 1992, pp. 1294-1294